Part IV: Leaders in healthcare marketing and communications talk about what their organizations are doing to ensure that diversity, equity, and inclusion continues to be a prominent part of the conversation, with actionable impact and results.
Part V: Leaders in healthcare marketing and communications share their thoughts on what excites them about the year ahead.
The top pharmaceutical companies and brands in this year’s Outcomes Creativity Index elevated their messaging by breaking down barriers, debunking myths and giving patients a stronger voice.
For Med Ad News’ 36th annual special report, the publication’s editors rank the world’s top 50 companies that generate revenue from prescription medicines and healthcare products.
The biopharma industry’s response to the global pandemic has propelled some COVID-19 vaccines into the leading ranks of the world’s best-selling products, with Pfizer/BioNTech’s Comirnaty surpassing AbbVie’s Humira for the No. 1 spot.
The values of leading pharmaceutical brands have skyrocketed during the COVID-19 pandemic; Johnson & Johnson retains the top position.
As the Manny Awards returned to an in-person event in April 2022 for the first time in three years because of the COVID-19 pandemic, many of the healthcare communications agencies and networks featured in Med Ad News’ annual special report are thriving.
R&D/Pipelines Report 2022: Innovating to turn the tide
BioNTech, BNT162b2 (Pfizer and BioNTech), Cancer Cells, CoronaVac (Sinovac Biotech), Covaxin (Bharat Biotech and ICMR), COVID-19 Vaccines, Eli Lilly, February 2022, Issue Archives, Janssen COVID-19 Vaccine (J&J), Moderna, mRNA-1273/Moderna COVID-19 Vaccine (Moderna), Pfizer, Product Pipelines, R&D, Sinopharm, Sinovac, Special Reports, Sputnik Light, Sputnik V vaccine, T-Cells, Therapeutics, Top 10 Pipelines, Vaxzevria (previously COVID-19 Vaccine AstraZeneca), ZyCoV-D (Zydus Cadila)The world’s leading COVID-19 vaccine and therapeutic manufacturers continue to develop treatments for the waves of variants as well as life-changing therapies for disease areas outside the world of coronaviruses. The world’s efforts to combat the global pandemic continue to evolve, as does Coronavirus Disease 2019 as variants and subvariants constantly toss volleys of grenades at the battlefront lines.
Executive management from healthcare communications agencies and networks weigh in on industry topics ranging from the COVID-19 pandemic to diversity, equity and inclusion.
Pfizer continues to make headlines with its COVID-19 initiatives, but the company prides itself in all of its scientific achievements and the financial muscle to back them up.